SCHEMBL15745866

SCHEMBL15745866

COC(=O)c1ccc(C(=O)NC2CCN(Cc3ccc(O)cc3)CC2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.60
▸ KMT2A Q03164 1/20 0.60
▸ TMEM97 Q5BJF2 3/20 0.59
▸ DRD4 P21917 1/20 0.59
▸ SIGMAR1 Q99720 3/20 0.59
▸ MCHR1 Q99705 3/20 0.59
▸ SLC6A12 P48065 1/20 0.59
▸ CYP1A2 P05177 1/20 0.59
▸ CYP3A4 P08684 1/20 0.59
▸ CYP2D6 P10635 1/20 0.59
▸ CYP2C9 P11712 1/20 0.59
▸ TSHR P16473 1/20 0.59
▸ MAPK1 P28482 1/20 0.59
▸ CYP2C19 P33261 1/20 0.59
▸ KDM4E B2RXH2 2/20 0.58
▸ CCR3 P51677 1/20 0.57
▸ KCNH2 Q12809 1/20 0.57
▸ LMNA P02545 1/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.56
▸ CHRM2 P08172 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15744773 0.88 KMT2A (0.62) MEN1KMT2ATMEM97DRD4SIGMAR1
SCHEMBL4340352 0.86 PRKAA2 (0.64) MEN1KMT2AMCHR1CYP3A4KCNH2
SCHEMBL12642632 0.83 SIGMAR1 (0.59) MEN1KMT2ATMEM97SIGMAR1MCHR1
SCHEMBL14100732 0.83 SIGMAR1 (0.62) DRD4SIGMAR1MCHR1KDM4E
SCHEMBL5315300 0.82 KDM4E (0.65) MEN1KMT2ADRD4SIGMAR1MAPK1
SCHEMBL9592422 0.82 DRD4 (0.79) MEN1KMT2ATMEM97DRD4SIGMAR1
SCHEMBL25013994 0.81 KDM4E (0.64) MEN1KMT2ADRD4MAPK1KDM4E
SCHEMBL12011091 0.80 KDM4E (0.57) MEN1KMT2ADRD4SIGMAR1MCHR1
SCHEMBL61848 0.80 TMEM97 (0.83) MEN1KMT2ATMEM97DRD4SIGMAR1
SCHEMBL22628859 0.79 KDM4E (0.68) MEN1KMT2AMAPK1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8871770-B2 Carboxamide compounds and methods for using the same MIDCAP FINANCIAL TRUST 2014-10-28 — — US disclosed
US-20140148467-A1 Carboxamide Compounds and Methods for Using the Same RIGEL PHARMACEUTICALS, INC. (US) 2014-05-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140148467-A1 Carboxamide Compounds and Methods for Using the Same PC, AK2, PRKAA2 MEN1 3205/4885KMT2A 324/4885TMEM97 2600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback